Profile | GDS5420 / 206313_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 31.32 | 24 |
GSM1296119 | B_lesional_pre-dose | 22.16 | 17 |
GSM1296076 | C_lesional_pre-dose | 18.38 | 15 |
GSM1296092 | D_lesional_pre-dose | 8.2 | 9 |
GSM1296103 | E_lesional_pre-dose | 36.82 | 27 |
GSM1296078 | F_lesional_pre-dose | ||
GSM1296107 | G_lesional_pre-dose | 29.53 | 20 |
GSM1296109 | H_lesional_pre-dose | 31.33 | 22 |
GSM1296080 | I_lesional_pre-dose | 6.44 | 7 |
GSM1296090 | J_lesional_pre-dose | 22.54 | 21 |
GSM1296074 | K_lesional_pre-dose | 44.06 | 31 |
GSM1296111 | L_lesional_pre-dose | 25.4 | 18 |
GSM1296099 | M_lesional_pre-dose | 24.68 | 21 |
GSM1296086 | O_lesional_pre-dose | 4.87 | 5 |
GSM1296117 | P_lesional_pre-dose | 49.02 | 27 |
GSM1296113 | Q_lesional_pre-dose | 125.02 | 42 |
GSM1296096 | R_lesional_pre-dose | 23.41 | 21 |
GSM1296105 | S_lesional_pre-dose | 38.3 | 26 |
GSM1296098 | T_lesional_pre-dose | 18.94 | 13 |
GSM1296101 | U_lesional_pre-dose | 53.15 | 32 |
GSM1296121 | V_lesional_pre-dose | ||
GSM1296088 | W_lesional_pre-dose | 22.08 | 20 |
GSM1296082 | X_lesional_pre-dose | 3.39 | 4 |
GSM1296115 | Y_lesional_pre-dose | 31.82 | 22 |
GSM1296084 | Z_lesional_pre-dose | ||
GSM1296072 | B_lesional_day8 | 25.48 | 19 |
GSM1296069 | L_lesional_day8 | 5.53 | 4 |
GSM1296071 | P_lesional_day8 | 69.07 | 32 |
GSM1296070 | Y_lesional_day8 | 61.54 | 31 |
GSM1296073 | V_lesional_day8 | 9.41 | 8 |
GSM1296034 | A_lesional_day15 | 13.67 | 12 |
GSM1296041 | G_lesional_day15 | 0.49 | 0 |
GSM1296035 | R_lesional_day15 | 59.98 | 35 |
GSM1296038 | U_lesional_day15 | 24.19 | 21 |
GSM1296047 | B_lesional_day15 | 32.53 | 21 |
GSM1296039 | E_lesional_day15 | 33.38 | 24 |
GSM1296042 | H_lesional_day15 | 13.51 | 10 |
GSM1296043 | L_lesional_day15 | 0.61 | 0 |
GSM1296037 | M_lesional_day15 | 9.8 | 8 |
GSM1296046 | P_lesional_day15 | 52.16 | 28 |
GSM1296044 | Q_lesional_day15 | 80.35 | 35 |
GSM1296045 | Y_lesional_day15 | 78.47 | 34 |
GSM1296025 | C_lesional_day15 | 37.98 | 27 |
GSM1296033 | D_lesional_day15 | 1.51 | 2 |
GSM1296027 | I_lesional_day15 | 19.45 | 20 |
GSM1296032 | J_lesional_day15 | 9.79 | 10 |
GSM1296024 | K_lesional_day15 | 7.27 | 7 |
GSM1296031 | W_lesional_day15 | 41.37 | 27 |
GSM1296028 | X_lesional_day15 | 27.38 | 22 |
GSM1296029 | Z_lesional_day15 | 19.55 | 18 |
GSM1296026 | F_lesional_day15 | 11.01 | 10 |
GSM1296030 | O_lesional_day15 | 7.68 | 9 |
GSM1296040 | S_lesional_day15 | 60.19 | 33 |
GSM1296036 | T_lesional_day15 | 19 | 16 |
GSM1296048 | V_lesional_day15 | 13.16 | 11 |
GSM1296059 | A_lesional_day43 | 59.74 | 35 |
GSM1296066 | G_lesional_day43 | ||
GSM1296060 | R_lesional_day43 | 35.22 | 26 |
GSM1296063 | U_lesional_day43 | 60.75 | 33 |
GSM1296064 | E_lesional_day43 | 21.79 | 19 |
GSM1296067 | H_lesional_day43 | 24.85 | 18 |
GSM1296062 | M_lesional_day43 | 24.31 | 21 |
GSM1296068 | Q_lesional_day43 | 37.38 | 22 |
GSM1296050 | C_lesional_day43 | 28.17 | 21 |
GSM1296057 | D_lesional_day43 | ||
GSM1296052 | I_lesional_day43 | 23.12 | 22 |
GSM1296054 | J_lesional_day43 | ||
GSM1296049 | K_lesional_day43 | 3.55 | 3 |
GSM1296055 | W_lesional_day43 | 12.64 | 12 |
GSM1296053 | X_lesional_day43 | 18.31 | 17 |
GSM1296058 | Z_lesional_day43 | ||
GSM1296051 | F_lesional_day43 | 15.9 | 14 |
GSM1296056 | O_lesional_day43 | 39.36 | 29 |
GSM1296065 | S_lesional_day43 | 48.28 | 30 |
GSM1296061 | T_lesional_day43 | 17.76 | 15 |
GSM1296095 | A_non-lesional_pre-dose | 28.86 | 24 |
GSM1296120 | B_non-lesional_pre-dose | 12.63 | 10 |
GSM1296077 | C_non-lesional_pre-dose | 24.5 | 21 |
GSM1296093 | D_non-lesional_pre-dose | ||
GSM1296104 | E_non-lesional_pre-dose | ||
GSM1296079 | F_non-lesional_pre-dose | 1.63 | 1 |
GSM1296108 | G_non-lesional_pre-dose | 27.94 | 21 |
GSM1296110 | H_non-lesional_pre-dose | 42.16 | 25 |
GSM1296081 | I_non-lesional_pre-dose | 8.08 | 9 |
GSM1296091 | J_non-lesional_pre-dose | 5.33 | 6 |
GSM1296075 | K_non-lesional_pre-dose | 15.18 | 14 |
GSM1296112 | L_non-lesional_pre-dose | 12.83 | 9 |
GSM1296100 | M_non-lesional_pre-dose | ||
GSM1296087 | O_non-lesional_pre-dose | 26.1 | 23 |
GSM1296118 | P_non-lesional_pre-dose | 37.06 | 23 |
GSM1296114 | Q_non-lesional_pre-dose | 93.08 | 37 |
GSM1296097 | R_non-lesional_pre-dose | 35.67 | 27 |
GSM1296106 | S_non-lesional_pre-dose | 40.83 | 27 |
GSM1296102 | U_non-lesional_pre-dose | 41.15 | 27 |
GSM1296122 | V_non-lesional_pre-dose | 4.87 | 4 |
GSM1296089 | W_non-lesional_pre-dose | 17.25 | 15 |
GSM1296083 | X_non-lesional_pre-dose | ||
GSM1296116 | Y_non-lesional_pre-dose | 49.98 | 26 |
GSM1296085 | Z_non-lesional_pre-dose |